Cheyne Capital Management (UK)’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Cheyne Capital Management (UK)’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-80,000	Closed	-$421K	–	27
2016 Q1	$421K	Sell	80,000 -19,000	-19%	-$116K	0.14%	30
2015 Q4	$778K	Sell	99,000 -121,618	-55%	-$1.05M	0.42%	23
2015 Q3	$1.86M	Sell	220,618 -129,986	-37%	-$1.2M	0.87%	17
2015 Q2	$3.84M	Sell	350,604 -132,658	-27%	-$1.7M	1.24%	12
2015 Q1	$6.75M	Buy	483,262 +73,547	+18%	+$1.12M	1.63%	13
2014 Q4	$6.92M	Buy	409,715 +82,894	+25%	+$1.21M	1.82%	10
2014 Q3	$4.39M	Buy	326,821 +206,821	+172%	+$2.46M	1.56%	11
2014 Q2	$1.53M	Hold	120,000	–	–	1.77%	17
2014 Q1	$1.43M	Buy	+120,000	New	+$1.61M	1.37%	19

Other funds holding INFI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cheyne Capital Management (UK)'s INFI Position: Q2 2016 in Review

Cheyne Capital Management (UK) sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2016, closing a stake of 80,000 shares — an estimated $421K sold.

Cheyne Capital Management (UK) first reported a position in INFI in Q1 2014 and held it in 9 quarters. The position peaked at $6.92M in Q4 2014. 107 funds tracked by Wall St. Rank hold INFI as of Q2 2016.

Cheyne Capital Management (UK) reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
Cheyne Capital Management (UK) sold 80,000 Infinity Pharmaceuticals, Inc. shares in Q2 2016, an estimated $421K.
Cheyne Capital Management (UK) first reported a position in Infinity Pharmaceuticals, Inc. in Q1 2014 and held it in 9 quarters.
Cheyne Capital Management (UK)'s Infinity Pharmaceuticals, Inc. position peaked at $6.92M in Q4 2014.
107 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2016.

Based on Cheyne Capital Management (UK)'s 13F filing for Q2 2016, filed 27 Jul 2016.